Cleared Traditional

K123079 - OLYMPIC BRAINZ MONITOR

K123079 is an FDA 510(k) clearance for OLYMPIC BRAINZ MONITOR, manufactured by Excel-Tech Ltd. (Xltek). The device is a Class 2 Neurology device with product code OMA cleared through the Traditional 510(k) pathway after a 219-day FDA review.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
May 2013
Decision
219d
Days
Class 2
Risk

K123079 is an FDA 510(k) clearance for the OLYMPIC BRAINZ MONITOR. Classified as Amplitude-integrated Electroencephalograph (product code OMA), Class II - Special Controls.

Submitted by Excel-Tech Ltd. (Xltek) (Oakville, CA). The FDA issued a Cleared decision on May 8, 2013 after a review of 219 days - an extended review cycle.

This device falls under the Neurology FDA review panel, regulated under 21 CFR 882.1400 - the FDA neurology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Neurology review framework, consistent with the majority of Class II 510(k) submissions.

View all Excel-Tech Ltd. (Xltek) devices

FDA 510(k) Submission Details - K123079

510(k) Number K123079 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received October 01, 2012
Decision Date May 08, 2013
Days to Decision 219 days
Submission Type Traditional
Review Panel Neurology (NE)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
71d slower than avg
Panel avg: 148d · This submission: 219d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

OMA Device Classification - Class 2, Special Controls

Product Code OMA Amplitude-integrated Electroencephalograph
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 882.1400
Definition Measure And Record Electrical Activity Of The Brain By Acquisition Of Amplitude-integrated Electroencephalograph (electroencephalograph Signals That Have Been Filtered And Displayed In A Specific Manner).
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Neurology devices follow this clearance model.

Regulatory Peers - OMA Amplitude-integrated Electroencephalograph

All 8
Devices cleared under the same product code (OMA) and FDA review panel - the closest regulatory comparables to K123079.
Neo
K192889 · Eemagine Medical Imaging Solutions GmbH · Jan 2020
Nihon Kohden QP-160AK EEG Trend Program
K163644 · Nihon Kohden Corporation · May 2017
CEREBRALOGIK- AEEG
K131789 · Mennen Medical , Ltd. · Dec 2013
NIHON KOHDEN QP-160 AK TREND PROGRAM WITH THE ADDITION OF DSA ASYMMETRY TREND AND FFT P
K120485 · Nihon Kohden America, Inc. · Mar 2012
NIHON KOHDEN QP-160AK EEG TREND PROGRAM
K092573 · Nihon Kohden America, Inc. · Jul 2010
OLYMPIC CFM 6000
K031149 · Olympic Medical Corp. · May 2003